Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Knight

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|May 26, 1983
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemiaM K Hostetter, H L Levy, H S Winter, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1987
Cigarette consumption and serum cotinine in relation to birthweightJ E Haddow, G J Knight, G E Palomaki, et al.
American Journal of Obstetrics and Gynecology|May 1, 1997
Maternal serum screening for Down syndrome in the United States: a 1995 surveyG E Palomaki, G J Knight, J E McCarthy, et al.
British Journal of Obstetrics and Gynaecology|September 1, 1991
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight deliveryJ E Haddow, G J Knight, E M Kloza, et al.
Prenatal Diagnosis|December 1, 1996
Refinements in managing maternal weight adjustment for interpreting prenatal screening resultsL M Neveux, G E Palomaki, D A Larrivee, et al.
Journal of Medical Screening|April 12, 2002
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndromeG E Palomaki, L A Bradley, G J Knight, et al.
Obstetrics and Gynecology|November 1, 1994
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defectsD N Saller, J A Canick, G E Palomaki, et al.
Lancet (London, England)|June 1, 1996
Computer software programs and Down's syndrome risk calculationsG J Knight, J E Haddow, G E Palomaki, et al.
Journal of Medical Screening|May 26, 2001
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screeningG J Knight, G E Palomaki, L M Neveux, et al.
Prenatal Diagnosis|March 1, 1993
Pregnancy associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancyG J Knight, G E Palomaki, J E Haddow, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|May 26, 1983
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemiaM K Hostetter, H L Levy, H S Winter, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1987
Cigarette consumption and serum cotinine in relation to birthweightJ E Haddow, G J Knight, G E Palomaki, et al.
American Journal of Obstetrics and Gynecology|May 1, 1997
Maternal serum screening for Down syndrome in the United States: a 1995 surveyG E Palomaki, G J Knight, J E McCarthy, et al.
British Journal of Obstetrics and Gynaecology|September 1, 1991
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight deliveryJ E Haddow, G J Knight, E M Kloza, et al.
Prenatal Diagnosis|December 1, 1996
Refinements in managing maternal weight adjustment for interpreting prenatal screening resultsL M Neveux, G E Palomaki, D A Larrivee, et al.
Journal of Medical Screening|April 12, 2002
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndromeG E Palomaki, L A Bradley, G J Knight, et al.
Obstetrics and Gynecology|November 1, 1994
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defectsD N Saller, J A Canick, G E Palomaki, et al.
Lancet (London, England)|June 1, 1996
Computer software programs and Down's syndrome risk calculationsG J Knight, J E Haddow, G E Palomaki, et al.
Journal of Medical Screening|May 26, 2001
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screeningG J Knight, G E Palomaki, L M Neveux, et al.
Prenatal Diagnosis|March 1, 1993
Pregnancy associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancyG J Knight, G E Palomaki, J E Haddow, et al.
Pageof 10